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INTRODUCTION
Lymphomas are the most common head 
and neck non-epithelial malignant tumors. They 
are divided into Hodgkin (HL) and non-Hodgkin 
lymphomas (NHL). Non-Hodgkin lymphomas 
account 60% of the cases and are categorized 
into B-cell (the more common type), T-cell, or 
NK-T-cell lymphomas1.
Some NHLs are extranodal, i.e., they 
involve tissues other than lymph nodes2.
Paranasal sinus lymphomas are rare, 
have poor prognosis, and their non-specific 
clinical signs may delay the production of a 
firm diagnosis2.
CASE REPORT
A 77-year-old male patient born in 
Itaperuna, State of Rio de Janeiro, came to our 
service complaining of dizziness, discomfort, 
headache, and vomiting that had persisted for 
30 days. He had no sinonasal symptoms. The 
patient underwent routine examination. Skull CT 
scans were ordered because of the symptoms 
he manifested, and a tumor with soft-tissue 
density measuring 19 x 20 x 30 mm was seen 
in the left posterior ethmoidal cells, in addition 
to erosion of the lamina papyracea (Figure 1). 
A rigid 0° scope was used to biopsy the patient. 
However, as the ethmoidectomy was performed, 
the surgeon felt the tumor could be easily re-
sected. The tumor was removed and sent to the 
pathologist for analysis. The report came back 
categorizing it as lymphoproliferative disease, 
and immunohistochemistry found it to be an 
aggressive, CD 20-positive (marker for B-cells), 
CD 45-positive (marker for lymphocytes) B-cell 
non-Hodgkin lymphoma with necrotic areas.
The patient was referred to oncology care 
and offered cycles of COP (cyclophosphamide, 
vincristine, and prednisone) along with confor-
mational radiotherapy with a total dose of 4140 
cGy/23 fractions. He responded well to the treat-
ment. Control contrast-enhanced CT scans taken 
six months after surgery did not reveal remaining 
disease or metastasis. However, the patient later 
developed severe interstitial pneumonia induced 
by cyclophosphamide toxicity and died.
DISCUSSION
Non-Hodgkin lymphomas rank second 
in prevalence among malignant neoplasms of 
the head and neck. They may have different 
cell phenotypes1 and are categorized as indolent, 
aggressive, and highly aggressive2.
The patient had diffuse large B-cell 
lymphoma - the most common subtype of 
NHL. This type of lymphoma accounts for 30% 
of NHL cases and usually involves males aged 
between 40 and 70 years. Diffuse large B-cell 
lymphomas are often aggressive, and include 
fast node involvement and extranodal disease 
in up to 40% of the cases3.
Approximately a third of the cases of 
NHL include extranodal disease and involve-
ment of the gastrointestinal tract, the skin, and 
the oral mucosa. Paranasal sinus lymphomas 
are seen in 9% to 13% of the cases, mainly in 
B-cell lymphomas, and involve the maxillary and 
ethmoid sinuses4.
Symptoms are generally non-specific, 
and may include repetition rhinosinusitis, nasal 
obstruction, pain, and facial edema4. B symptoms 
(fever > 38° C, nocturnal sweating, and 10% 
weight loss in six months) occur in 40% to 45% of 
the cases, and even more frequently in aggressi-
ve disease5. As the disease evolves, necrosis and 
bone lysis set in, producing fetid odors.
Diagnosis is performed through meticu-
lous physical examination of the head and neck 
and imaging. Histopathological testing of the 
tumor confirms the diagnosis of lymphoma and 
immunophenotyping differentiates primary nasal 
lymphoma - derived from T-cells - from B-cell 
nasopharyngeal lymphoma (69%)4,5.
According to the Ann Arbor staging 
system (also used for HL), our patient was on 
stage IEA, as only one extranodal structure 
was involved (ethmoid sinus) and he had no B 
symptoms, thus excluding other possible primary 
involvement sites5.
Treatment is based on surgery, systemic 
chemotherapy, and localized radiotherapy, and 
patient mean survival is five years. Regional and 
distal metastases are rare4,5.
CONCLUSION
Lymphomas are the most frequent 
non-epithelial malignant tumors of the nose, 
and must be included in the differential diag-
nosis of paranasal sinus neoplasms. Proper 
workup and definitive diagnosis are funda-
mental for the early introduction of treatment 
and improved survival of NHL patients.
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Figure 1. Axial view CT scan: soft-tissue density tumor in left 
posterior ethmoidal cells measuring 19 x 20 x 30 mm.
